TrialBritish journal of cancer2022

Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).

Sukeshi Patel Arora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.